Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The FUDsters on this board will likely withdraw like rats and cockroaches when the lights are turned on after MAA approval....
You don't dedicate 20+ years of your adult career to a scam. Then hold millions of shares while the value declines without selling any. $NWBO team members
You don't take on a legal case on contingency if the facts and law are against you. LP of Cohen Milstein
You don't continue to receive grant after grant for federal funding of research, year after year, for the same basic protocol immunotherapy if your patients are dying at the same rate of the standard of care. LL of UCLA Medical (Nobel Prize candidate?)
You don't sign your name to an article published in one of the most prestigious medical journals if you don't believe the science. JAMA article authors Nov. 17, 22.
...and if you've invested into $NWBO and been watching real progress of the company, while reading all the intelligent, well-documented and fact-supported postings across the realm of social media and sites like this one, you do not SELL your shares...
Hindsight's 20:20, and if I would have seen the real manipulation going on and recognized the years required from data lock due to COVID and the novelty (and difficulty) of regulatory approval, and been realistic that the Defendants were simply in too deep to claw their way out of their naked short position, I would have patiently bought on all the lows of the past 3 years and would now be holding millions more shares myself. My hope is that on top of the incredible returns coming to me and my fellow longs out there, we will witness a short-squeeze like no other and have the cajones (i.e. courage) to HOLD in the face of a $100+ share price to watch it push higher.
45 M Short Interest - new high 7-31-23!
Hey LC - I've been in manufacturing for more than 3 decades, but I don't know what it takes to be a QP for Advent/NWBio....do you? I'll trust the Doc on this one. If it were that easy, the Chinese would have already found a way to do it without $NWBO by now...surely they have their spies here, even before the border was opened.
Don't forget the recent objective "article" (ahem, editorial) on that so-called science website by a conflicted doctor.
When you're splitting the atom for the first time, the timeline for achievement is not predictable.
$NWBO Progress continues to be made, people are being hired, regulatory approvals continue to appear, final application documents continue to be drafted and checked. If you're an investor worried about share price today for an investment that will set your family up for generations of wealth, then sell and get out now, because it is likely to fall further in the short-term.
If, on the other hand, like me, have time to wait it out, and wish you had more cash to invest, then grab some popcorn and enjoy the show. A pre-revenue biotech startup is not for the faint hearted, but this one continues to plod itself forward towards the history books as one of the best results for humanity.
exit Soap Box.
Really JD? - owning nearly 40M shares herself and she doesn't care about share price?!
I can see the turnip truck in my rear view mirror, as can everyone else.
Vator - overreaction - he was asking, not stating....did it come from combo. partners?
Dear ExW - Please enlighten folks here of the timelines typically encountered by personalized vaccines, especially those with orphan disease status (or similar fatal diagnoses).
referring to DCVax-L from $NWBO as a 'drug' is an obvious attempt to slight what DCVax-L is, as if it weren't an incredibly personal vaccine, not a drug!
Does it really matter if placebo patients were compared? These types of out-of-context fabricated statements are only meant to dissuade superficial retail shareholders.
The JAMA article puts all of this nonsense to bed, and in combination with Checkpoint Inhibitors, DC-Vax L crushes it with OVERALL SURVIVAL of 50% of patients at the 10-year mark !!!!
exwannabe and others just have some ridiculous axe to grind and don't care about misleading folks.
Patients know, the FDA and NIH know (SPORE grants to UCLA), certainly MHRA/NICE know, the Brain Tumor Charity and numerous other cancer centers and their doctors know the promise of DC-Vax from $NWBO. The insiders at NVCR also know it.
Nobel Prize in medicine for Dr. Linda Liau !!!
Question: Why would the $BMY and $NWBO clinical trial list a Lung tumor vaccine? Was this a typo, or carry over from another
clinical trials.gov NCT03014804
TERTIARY OBJECTIVES....
GROUP I: Patients receive dendritic cell-autologous lung tumor vaccine intradermally (ID) on days 0, 7, 14, and weeks 4, 6, 8, 11, 14, 17 and 20.
GROUP II: Patients receive dendritic cell-autologous lung tumor vaccine as in Group I, and nivolumab intravenously (IV) over 30 minutes on days 0, 14, and weeks 4, 6, 8, 11, 14, 17, and 20.
No clue. I would imagine Cofer Black and Cohen Milstein have a good idea. Perhaps we'll learn more as the lawsuit progresses.
Record high 42M legit. Shorts - 42 M as of 6-15-23 in $NWBO
Next week could be explosive!!!
$NWBO Fails-To-Deliver 2H May just $0.2M
$NWBO
Probably more 'follow the leader' because NBC Nightly News did a report on Survax-M, lauding the possibility of a GBM cancer vaccine with no mention of NWBO DCVax-L.
Looks like someone is doing a PR campaign that is effective.
I especially like the last sentence..."Once the MAA is deemed acceptable by the MHRA, the agency can then proceed with the inspection of the manufacturing facility and the granting of the MIA."
It is logical that MHRA would not dedicate its personnel to manufacturing process review (MIA) without having the complete picture and a committed applicant (as would be demonstrated by a nearly-complete product approval application for MAA).
Go NWBO !!!
Don’t fall for it, too obvious a remark without context. Probably a fudster trying to trap some eager beavers into whatever.
Far too conservative - I believe $NWBO market cap will be stable above $30B by end of 2024.
$NWBO Advent Milestones 9/10 milestones achieved....MAA next and Final !!?!!
insert-text-here
$NWBO Short Interest has increased 2.4 M shares in 1H May.
Is your brokerage house using your shares (held in Margin accounts) to earn interest from hedge funds for shorting purposes? Check with your broker to see if your shares are held in a margin account. Are they at least paying you for the privilege to lend your shares ? Move them out of margin accounts to avoid giving the shorts the ammunition to drive down the SP.
Scotty - In english, the word 'if' actually implies a hypothetical. not a fact.
$NWBO
Another question - how many of us long NWBO shareholders are in fact 'owed' actual shares from these market makers like Citadel, Virtu, etc.? I know my broker (Fidelity) shows that I own shares, but if CITADEL and others vanish as a result of numerous spoofing lawsuits, who must deliver the shares? I would think the brokerage firms have a fiduciary obligation to us account holders. If the 7 Defendants vanish or are unable to deliver, then who is left holding the bag?
Dear frog - $NWBO - I think you meant January 2023.
Reading between the lines, it would seem from your post that MIA for Advent/Sawston may have been granted w/o the Flaskworks automated production equipment being fully ready for commercial production. Is that even possible? Would UK MHRA give commercial license for production on a system that has not yet proven itself? Or, could you give more clarity on the 'biosensor' and 'programming' issues (if known)? Were the issues resolved? Or, are they now the subject of a 'comparability study' to validate the FlaskWorks system by the end of this year (2023)?
Did I read "GBM Cure" somewhere in between the lines?! Thanks for the post hoffman6383!
$NWBO and DCVax (murcidencel) are coming to a regulatory agency near you.
Were any of those trials sponsored (i.e. funded) by NWBO? Please provide specific NCT numbers from clinicaltrials.gov
Nicely done aek !
3M doses is not a lot considering they will likely have to produce double or triple the anticipated number to be actually used, and for future in case of recurrence. Just assume 30 doses/patient and you quickly get down to just 100,000 patients. Perhaps others have more intimate experience in this field, but I can imagine further investment into storage will become necessary down the road.
Picked up another 20k shares of $NWBO this week around $0.81. Thank you to the market makers, and those short term weak-handed investors.
Musella Webinar w/Dr. LL Video Dr. LL + Al Musella Dec-22.
Locked and Loaded this morning! [img][/img]
Abt. 30 min ago, 1.0 M shares were borrowed for shorting. I am ready to buy the dip. :)
Good job $NWBO Longs !! lull the likes of exwannabe, jdart, fartstain, and several other fudsters (you know who you are) and their Sauron MM's (LOTR analogy for those with quizzical looks). Let them dig the hole deeper and work their butts off pushing SP down to meet some magical prediction of 'even lower' so they can say I told you so, and then we'll all magically believe that they were right and we were wrong and relent and sell cheap so they can begin to fill the incredible chasm of SHORT INTEREST they've created BEFORE judgement day. I on the other hand will be ready to purchase even more at artificially depressed prices.
A word to the wise of those new to the party, with belief in the incredible scientists and doctors behind the TLD and JAMA Oncology peer-reviewed journal article and management teams who continue pushing the ball down the field weathering the onslaught of multi-billion and nearly trillion dollar hedge funds....understand that OTC stocks are easily manipulated...until they aren't ! Let that sink in....
It would not make sense to go through all this effort of obtaining mfg. approval for commercial production using the old manual method (very labor intensive). I am expecting that the flaskworks system is at the heart of the next MIA approval in Sawston. IMHO
In a normal market, probably negative...with MMs in control, business as usual. So much will happen before these authorized shares are needed (if at all) that the thought of more dilution will be #30 on list of items to discuss. However, not having more shares available (look up the definition of the word 'Authorized') for funding WILL be a #1 issue if other avenues of financing are not available.
True. but borrowed shares went up 1 hr ago. There are none left to borrow from a large brokerage firm that had 9 M shares available before then JAMA Oncology article. Someone is gearing up to counter the pending good news. IMHO
Dear Sir Pumpernickel or Rye or Wheat or Wholegrain (which Jester crowned you?). If you have been keeping up with 10-Qs and annual reports, the company has a plan for regulatory approval, secured PIP mid-year 2022 and has tasked Advent Bioservices with completing much of the UK MHRA approval process. Why forecast too much and entice more FUDsters like you.
Now, with the JAMA Oncology, peer-reviewed successful results and support of key influencers, we are in the 4th quarter with the ball in the red zone (NFL football analogy for you and your tiddly winks compadres), with the right game plan and the lead. On a shoestring budget, against headwinds of MM's worth Trillions of dollars shorting the hell out of the stock, underhanded competitors not wanting to be displaced, not to mention FINRA/SEC looking the other way....this DAVID is about to slay not only Goliath, but take the crown as Cancer Killer.
p.s. would you like some cheese to go with that whine?
Extending the SOW could just be a headfake as well. Lulling MM's into a comfortable position extending their risk-taking posture for the MOASS. :)
temporary....buying more tomorrow.